从“展品”到“药品”，从“首展”到“首用”，吉利德科学借进博会“黄金跑道”持续跑出“中国速度”。2025年11月5日，企业将以500平方米展台四度赴约，把刚刚获得美国FDA批准的Lenacapavir（来那帕韦）亚洲首展搬上国家会展中心，并同步亮出罕见病新药Seladelpar与13款已上市创新药，用“全球同步研发—乐城同步落地—进博同步展示”的闭环，重申中国在其全球版图的核心战略地位。美国获批的...
Source Link从“展品”到“药品”，从“首展”到“首用”，吉利德科学借进博会“黄金跑道”持续跑出“中国速度”。2025年11月5日，企业将以500平方米展台四度赴约，把刚刚获得美国FDA批准的Lenacapavir（来那帕韦）亚洲首展搬上国家会展中心，并同步亮出罕见病新药Seladelpar与13款已上市创新药，用“全球同步研发—乐城同步落地—进博同步展示”的闭环，重申中国在其全球版图的核心战略地位。美国获批的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.